Skip to content

Clinical trials

Phase 2 Adrenal Hyperplasia, Congenital trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adrenal Hyperplasia, Congenital Phase: Phase 2 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20132
20161
20171
20183
20191
20201
20212
20233
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Terminated4
Active, not recruiting2
Not yet recruiting2
Withdrawn1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Spruce Biosciences5
Mayo Clinic3
Neurocrine Biosciences3
Crinetics Pharmaceuticals Inc.2
Neurocrine Switzerland GmbH2
Boston Children's Hospital1
H. Lundbeck A/S1
Haukeland University Hospital1
Millendo Therapeutics US, Inc.1
Millendo Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adrenal Hyperplasia, Congenital23
ACTH Syndrome, Ectopic3
Adrenal Gland Diseases3
Cushing Syndrome3
Adrenal Insufficiency2
Endocrine System Diseases1
Hyperandrogenism1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.